Leveraging Partnerships With Drug Manufacturers To Overcome 340B Restrictions On Specialty Drugs

March 1, 2024340B, 340B ESP, Bedside Prescription Delivery, Drug Manufacturer Restrictions, Medicare, Meds To Beds, PBM, Specialty Drugs, Specialty Drugs, Specialty Pharmacy

It’s no secret that the 340B Drug Pricing Program has been a lifeline for eligible health systems, enabling them to fill-in the massive revenue gaps inherent to the non-profit-hospital business model (and, in the process, support their mission of providing quality care to our nation’s most vulnerable patients) through access to discounted prescription refills. At … Read More

ProxsysRx’s Meds To Beds Program Makes Immediate Impact Upon Launch At TMH

November 8, 2023340B, Bedside Prescription Delivery, Meds To Beds, Prescription Discounts, Retail / Outpatient Pharmacy, Specialty Pharmacy

To date, we’ve published a dozen posts either detailing, or mentioning-in-passing, the clinical and financial benefits a well-run Meds To Beds program offers hospitals and the patients they serve. Which is why we thought it was time to report some of the personal benefits our program delivers — with a handful of stories we’ve heard … Read More

Leveraging Partnerships With Drug Manufacturers To Overcome 340B Restrictions On Specialty Drugs

October 26, 2023340B, 340B ESP, Bedside Prescription Delivery, Drug Manufacturer Restrictions, Medicare, Meds To Beds, PBM, Specialty Drugs, Specialty Drugs, Specialty Pharmacy

Since the advent of 340B ESP in 2020, drug manufacturers have imposed a raft of unlawful restrictions on 340B program savings. Nowhere have those restrictions been more punitive than with specialty pharmacy medications; drugs which typically represent the most expensive (and profitable) in manufacturers’ product lines. 340B restrictions from the drug manufacturers’ perspective That said, … Read More

So You Want To Build An Outpatient Pharmacy For Your Hospital? Here’s What’s Involved.

October 9, 2023340B, Bedside Prescription Delivery, Meds To Beds, Meds To Beds, Prescription Discounts, Retail / Outpatient Pharmacy

On June 12, ProxsysRx opened its pharmacy in Holyoke Medical Center — a 198-bed independent community hospital in Holyoke, Massachusetts. The pharmacy is currently offering full retail service, and some patient-discharge prescription support (Meds To Beds), but the Employee Prescription plan still has a few hurdles to overcome. It’s a still-unfinished process that began when … Read More

Terrebone Pharmacist-In-Charge Derel Smith Is “At Home” In Houma

October 2, 2023Bedside Prescription Delivery, Meds To Beds, Pharmacy Careers, ProxsysRx Profiles, Retail / Outpatient Pharmacy

Few corporate ladders in the retail pharmacy world rise higher than Derel Smith’s did. As former Director of Pharmacy Operations for a major regional retailer, he managed oversight of nearly 600 pharmacies. It was a position nearly 30 years in the making, and one that afforded him an enviable lifestyle in Orlando. So why, you’d … Read More

The 2023 Guide To Implementing An Effective 340B Program

May 24, 2023340B, 340B ESP, Bedside Prescription Delivery, Compliance, Covered Entities, Drug Manufacturer Restrictions, Meds To Beds, PBM, Requirements, Specialty Drugs, Specialty Drugs, Specialty Pharmacy, Specialty Pharmacy, TPA / TPAs

The 340B-program landscape has changed dramatically. For the 340B program’s first 28 years after its 1992 inception, the basic list of Best Practices for eligible entities (the 340B basics, if you will) remained largely unchanged — aside from the dramatically-increased importance of using specialized software. But since the June, 2020 introduction of 340B ESP — … Read More

How To Manage A Director of Pharmacy’s Responsibilities And An Optimized 340B Program. Without Hiring More Staff.

March 9, 2023340B, 340B ESP, Bedside Prescription Delivery, Compliance, Contract Pharmacy, Meds To Beds, Outpatient Tracking, Patient Eligibility, Retail / Outpatient Pharmacy, Specialty Pharmacy

Two DOPs Deal With Operations, The 340B Program, And Drug Manufacturers’ Restrictions ProxsysRx recently organized an introductory Zoom meeting between the DOPs of two health systems we serve: Southwest Mississippi Regional Medical Center’s (SMRMC) Tiffany Poole and Andrew Wright of  Conway Medical Center (CMC). ANDREW CMC is a private non-profit, acute care DSH (Disproportionate Share Hospital) … Read More

How 340B Programs Can Positively Impact Value-Based Care Scores

March 9, 2023340B, Bedside Prescription Delivery, CMS Star Ratings, Covered Entities, Medicare, Medication Compliance, Meds To Beds, Meds To Beds, Outpatient Tracking, Overview, Patient Eligibility, Readmissions Reduction, Value-Based Care

It’s no secret that, for hospitals, one of the Affordable Care Act’s most far-reaching legacies is the impact that Value-Based Care has on the payments they receive. For many health systems, the lower their Value-Based Care scores, the lower the payments they receive from treating Medicare and Medicaid patients. What isn’t as commonly considered — … Read More

How To Manage A Director of Pharmacy’s Responsibilities And An Optimized 340B Program. Without Hiring More Staff.

November 9, 2022340B, 340B ESP, Bedside Prescription Delivery, Compliance, Contract Pharmacy, Meds To Beds, Outpatient Tracking, Patient Eligibility, Retail / Outpatient Pharmacy, Specialty Pharmacy

Two DOPs Deal With Operations, The 340B Program, And Drug Manufacturers’ Restrictions ProxsysRx recently organized an introductory Zoom meeting between the DOPs of two health systems we serve. Southwest Mississippi Regional Medical Center’s (SMRMC) Tiffany Poole earned her Doctorate of Pharmacy degree from the University of Mississippi in 2006. A ProxsysRx pharmacist since 2018, she … Read More

How Outpatient Pharmacies in Hospitals Impact the True Costs of Readmissions

May 31, 2022Bedside Prescription Delivery, CMS Star Ratings, Medication Compliance, Meds To Beds, Meds To Beds, Prescription Discounts, Readmissions, Readmissions Reduction, Retail / Outpatient Pharmacy

How can outpatient pharmacies reduce hospital readmissions? We’ve reported the following statistical finding elsewhere in this forum, but it bears repeating: Up to 70% of all preventable outpatient hospital readmissions are due to prescription non-compliance. Making matters worse for hospitals, the analytics generated by ProxsysRx’s proprietary software indicate that average hospital readmissions from prescription non-compliance … Read More